Lipocalin 2 expression is associated with aggressive features of endometrial cancer

BACKGROUND: Increased expression of lipocalin 2 (LCN2) has been observed in several cancers. The aim of the present study was to investigate LCN2 in endometrial cancer in relation to clinico-pathologic phenotype, angiogenesis, markers of epithelial-mesenchymal transition (EMT), and patient survival....

Descripción completa

Detalles Bibliográficos
Autores principales: Mannelqvist, Monica, Stefansson, Ingunn M, Wik, Elisabeth, Kusonmano, Kanthida, Raeder, Maria B, Øyan, Anne M, Kalland, Karl-Henning, Moses, Marsha A, Salvesen, Helga B, Akslen, Lars A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493289/
https://www.ncbi.nlm.nih.gov/pubmed/22559235
http://dx.doi.org/10.1186/1471-2407-12-169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493289/
https://www.ncbi.nlm.nih.gov/pubmed/22559235
http://dx.doi.org/10.1186/1471-2407-12-169

Ejemplares similares